INSIGHT: A Tool for Fit-for-Purpose Evaluation and Quality Assessment of Observational Data Sources for Real World Evidence on Medicine and Vaccine Safety

Author:

Hoxhaj VjolaORCID,Andaur Navarro Constanza L.ORCID,Riera-Arnau JuditORCID,Elbers Roel JHJ,Alsina Ema,Dodd Caitlin,Sturkenboom Miriam CJMORCID

Abstract

ABSTRACTObjectiveTo describe the development of INSIGHT, a real-world data quality tool to assess completeness, consistency, and fitness-for-purpose of observational health data sources.Material and MethodsWe designed a three-level pipeline with data quality assessments (DQAs) to be performed in ConcePTION Common Data Model (CDM) instances. The pipeline has been coded using R.ResultsINSIGHT is an open-source tool that identifies potential data quality issues in CDM-standardized instances through the systematic execution and summary of over 588 configurable DQAs. Level 1 focuses on compliance with the ConcePTION CDM specifications. Level 2 evaluates the temporal plausibility of events and uniqueness of records. Level 3 provides an overview of distributions, outliers, and trends over time. The DQAs are run locally and assessed centrally by a data quality revisor together with the data access provider’s representatives.DiscussionNSIGHT aligns with recent conceptual frameworks that identify five dimensions of data quality: reliability, extensiveness, coherence, timeliness, and relevance. Data quality is the sum of several internal and external features of the data and while DQAs provide reassurance about fitness-for-purpose for secondary-use data sources, improvements in data collection and generation stages are essential to reduce bias, misclassification, and measurement errors, thereby enhance overall data quality for Real World Evidence.ConclusionINSIGHT aims to support clinical and regulatory decision-making for medicines and vaccines by evaluating the quality of observational health data sources to support fit for purpose assessment. Assessing and improving data quality will enhance the reliability and quality of the generated evidence.

Publisher

Cold Spring Harbor Laboratory

Reference29 articles.

1. U.S. Food and Drug Administration. Framework for FDA’s Real-World Evidence Program. Published 2023. Accessed February 1, 2023. https://www.fda.gov/media/120060/download

2. Heads of Medicines Agency. European Medicines Agency HMA-EMA Joint Big Data Taskforce Summary Report. Accessed February 1, 2023. https://www.ema.europa.eu/en/documents/minutes/hma/ema-joint-task-force-big-data-summary-report_en.pdf

3. Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?

4. Real world data and data science in medical research: present and future

5. Inclusion of pregnant and breastfeeding women in research - efforts and initiatives

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3